Invasive treatment performed for acute myocardial infarction in a patient with immune thrombocytopenic purpura.
Acute myocardial infarction (AMI) is infrequent in patients with idiopathic thrombocytopenic purpura (ITP) so the best treatment is not well known. The next case shows a 37-year-old man with chronic ITP who suffered an anterior AMI, the platelet count at admission was 39,000 microL. He was treated successfully with primary percutaneous angioplasty under anticoagulation with unfractionated heparin and antiaggregation with clopidogrel and ASA. At the end of the procedure we sealed the femoral access site with Angio-Seal(R). He didn t have any complications during the procedure and after six months remained asymptomatic. In some patients with chronic ITP and AMI the percutaneous treatment could be a good option.
Maria Cruz Ferrer
MC
Gracia
Isabel Calvo
IC
Cebollero
Juan Sánchez-Rubio
JS
Lezcano
Gabriel Galache
GG
Osuna
José Antonio Diarte
JA
Miguel
Luis Placer
LP
Peralta
D000328:Adult; D015906:Angioplasty, Balloon, Coronary / Q000379:methods; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000175:diagnosis / Q000628:therapy*; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000175:diagnosis / Q000628:therapy*; D016896:Treatment Outcome